@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-GZ0L4XMG-7
  skos:prefLabel "Inhibiteurs du symport chlorure sodium"@fr, "Sodium Chloride Symporter Inhibitors"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-QLJPRJFD-L
  skos:prefLabel "Chlorothiazide"@fr, "Chlorothiazide"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-K5JBXNX3-T .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-FG8LP9J8-Q
  skos:prefLabel "Antihypertensive Agents"@en, "Antihypertenseurs"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-RZWRW1JM-Z
  skos:prefLabel "Diurétiques"@fr, "Diuretics"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-T40FKJTD-W
  skos:prefLabel "Trichlorméthiazide"@fr, "Trichlormethiazide"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-K5JBXNX3-T .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-K5JBXNX3-T
  skos:narrower jvr:-T40FKJTD-W ;
  mesh:pharmacologicalAction jvr:-RZWRW1JM-Z, jvr:-GZ0L4XMG-7, jvr:-FG8LP9J8-Q ;
  mesh:allowableQualifier jvr:-WK5F724J-1, jvr:-NB0XHT3S-N, jvr:-FWD2BGQ0-9, jvr:-G4R176S9-J, jvr:-T9HQD7ST-J, jvr:-D0F21513-5, jvr:-XV06LPML-W, jvr:-NFTHND7Q-8, jvr:-L6C0XPHT-4, jvr:-HQRFT0C6-B, jvr:-SBNWSM1T-R, jvr:-R3QWLHRG-V, jvr:-R0ZCQ8X6-J, jvr:-THHNVC7V-3, jvr:-S0CS1X5R-5, jvr:-BT300B3G-Q, jvr:-W6SQV79N-S, jvr:-CB30NGKB-3, jvr:-G30ZJ446-J, jvr:-TJHVZCRZ-0, jvr:-NKM836P1-M, jvr:-NHL3D2X0-S, jvr:-M63HSDM7-1, jvr:-H7K65Q8S-Z, jvr:-Q3979798-W ;
  dc:modified "2016-05-31"^^xsd:date ;
  skos:inScheme jvr: ;
  dc:established "1966-01-01"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D006852> ;
  dc:created "1999-01-01"^^xsd:date ;
  skos:broader jvr:-QLJPRJFD-L ;
  skos:altLabel "0J48LPH2TH"@fr, "0J48LPH2TH"@en, "2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide"@fr, "2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide"@en, "Dihydrochlorothiazide"@en, "58-93-5 (Hydrochlorothiazide)"@fr, "58-93-5 (Hydrochlorothiazide)"@en, "Dichlothiazide"@en, "HCTZ"@en ;
  skos:hiddenLabel "Oretic"@en, "Sectrazide"@en, "HydroDIURIL"@en, "Esidrex"@en, "Esidrix"@en, "Hypothiazide"@en ;
  a skos:Concept, mesh:Descriptor ;
  skos:definition "A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism."@en ;
  skos:prefLabel "Hydrochlorothiazide"@en, "Hydrochlorothiazide"@fr .

